Mihael H. Polymeropoulos | President, Chief Executive Officer and Chairman of the Board |
Kevin Moran | Senior Vice President, Chief Financial Officer and Treasurer |
Tim Williams | General Counsel |
Andrew Tsai | Jefferies |
Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2023 Vanda Pharmaceuticals Inc. Earnings Call. All lines have been placed on mute to prevent any background noise.